Closed · CDC-RFA-CD-23-0057 · CFDA 93.135 · Discretionary

Increasing Public Awareness and Provider Education About Primary Immunodeficiency Disease

Federal grant opportunity posted by Centers for Disease Control - OD, cataloged on Grants.gov.

$1M-$3M
Award range
Closed
Status
May 22, 2023
Close date
1
Expected awards

The verdict

Increasing Public Awareness and Provider Education About Primary Immunodeficiency Disease is a closed discretionary listing from Centers for Disease Control - OD that offered $1,000,000 -- $3,000,000 across 1 expected award. Future funding cycles may be published under the same CFDA number.

$1M-$3M
award range
Closed
application status
1
expected award
93.135
CFDA program

Opportunity snapshot. This Grants.gov announcement - Increasing Public Awareness and Provider Education About Primary Immunodeficiency Disease - is cataloged under number CDC-RFA-CD-23-0057 and tied to CFDA assistance listing 93.135, posted by Centers for Disease Control - OD. Grants.gov currently shows the opportunity as closed, first posted on April 7, 2023. The funding category is Discretionary, delivered as a grant.

Award economics. The award range on file is $1,000,000 -- $3,000,000. The agency has projected $15.0 million in total estimated funding for this announcement. It expects to issue 1 award. If the agency funds the expected 1 award from the $15.0 million estimated pool, the average award works out to roughly $15.0 million. Cost sharing is not required, so applicants do not need to commit matching funds to be competitive on this opportunity. Federal award ranges are often upper bounds; actual allocations reflect program appropriations, the strength of the applicant pool, and the evaluation committee's scoring.

Deadline and action path. This opportunity closed on May 22, 2023. Future funding cycles may be published under the same CFDA number, so monitoring the parent program page is the most reliable way to catch re-announcements. Every Grants.gov submission requires an active SAM.gov registration and a Unique Entity ID. Review the Eligibility section below carefully, federal eligibility categories (nonprofit, state or local government, tribal, individual, educational institution, small business) have distinct registration and reporting requirements. Pre-application outreach to the listed agency contact is permitted and often welcomed, it helps clarify scope and scoring priorities. Before acting on the deadline or award figures above, verify them directly on the official Grants.gov listing, amendments can change dates and amounts after this page was last refreshed.

Award Range

$1,000,000 -- $3,000,000

Close Date

May 22, 2023

Electronically submitted applications must be submitted no later than 11:59 pm ET on the listed application due date.

Posted

April 7, 2023

Est. Total Funding

$15,000,000

Expected Awards

1

Instrument

Grant

Description

Primary Immunodeficiency Diseases (PID) are a group of primarily single-gene disorders of the immune system. Primary denotes the genetic nature of the defects, differentiating them from secondary or acquired immunodeficiencies caused by malnutrition, infection, chemotherapy, or other external agents. The defining characteristics of primary immunodeficiency diseases make them candidates for a public health intervention approach. Although the clinical manifestations and underlying genetic defects are diverse, primary immunodeficiency diseases share the common feature of increased susceptibility to infection and collectively result in substantial morbidity and shortened life spans. However prompt diagnosis and treatment can be lifesaving and may result in marked improvements in the quality and length of life. The heterogeneity of primary immunodeficiency diseases and the limited understanding of the relation between genotype and phenotype also hinder intervention efforts. Additional obstacles include the difficulty of diagnosis in the absence of a high index of suspicion and the lack of awareness of health care providers and the public which impedes the timely recognition of affected person by using a combination of clinical suspicion and diagnostic testing.

Eligibility

Grants.gov lists this opportunity under eligibility category codes 00, 01, 02, 04, 05, 06, 07, 08, 11, 12, 13, 20, 99. These codes correspond to applicant types (state/local government, tribal organization, nonprofit, educational institution, individual, small business, etc.) defined in Grants.gov's own eligibility reference. See the current Grants.gov eligibility categories or check the official listing below for this opportunity's exact eligibility statement.

Official Listing on Grants.gov

View full details, application forms, and submission instructions.

View on Grants.gov

Agency Contact

Scott Bowen msb4@cdc.gov

Key Dates

Posted April 7, 2023
Close Date May 22, 2023
Archive Date June 22, 2023
Last Updated April 7, 2023

Frequently Asked Questions

What is this grant opportunity?
This is a federal funding opportunity titled "Increasing Public Awareness and Provider Education About Primary Immunodeficiency Disease", offered by Centers for Disease Control - OD. It is associated with CFDA program 93.135. Primary Immunodeficiency Diseases (PID) are a group of primarily single-gene disorders of the immune system. Primary denotes the genetic nature of the defects, differentiating them from secondary or a...
Is this opportunity still open?
No, this opportunity is closed. It closed on May 22, 2023. Check the parent program page for future funding cycles.
How much funding is available?
The award range for this opportunity is $1,000,000 -- $3,000,000. Total estimated funding: $15,000,000. Expected number of awards: 1.
How do I apply?
Applications for federal grant opportunities are typically submitted through Grants.gov. Visit the official listing at grants.gov for application instructions, required documents, and submission deadlines.

Disclaimer: This information is sourced from Grants.gov and SAM.gov and is for informational purposes only. Opportunity details, deadlines, and eligibility requirements change frequently. Always verify current information directly on Grants.gov before applying. PlainGrants is not affiliated with any federal agency.

Data sourced from the SAM.gov Assistance Listings and Grants.gov. See our methodology for details. Retrieved and formatted by PlainGrants